日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Predicting metabolic dysfunction-associated steatotic liver disease risk using patient-derived induced pluripotent stem cells

利用患者来源的诱导多能干细胞预测代谢功能障碍相关的脂肪肝疾病风险

Qin, Yuanyuan; Chhetri, Parth; Theusch, Elizabeth; Lim, Grace; Teker, Sheila S; Kuang, Yu-Lin; Aziziraftar, Shahrbanoo Keshavarz; Mehraban, Mohammad Hossein; Munoz-Howell, Antonio; Saxena, Varun; Le Guillou, Dounia; Mattis, Aras N; Maher, Jacquelyn J; Medina, Marisa W

The prevalence of autoimmune hepatitis is rising: Estimates and trends from a large, multi-ethnic cohort in the United States

自身免疫性肝炎的患病率正在上升:来自美国大型多民族队列的估计和趋势

Yao, Jimmy; Jiang, Sheng-Fang; Kapoor, Chandni; Balasubramanian, Sripriya; Ramalingam, Nirmala D; Saxena, Varun; Radhakrishnan, Kavita

Predicting Metabolic Dysfunction Associated Steatotic Liver Disease Risk Using Patient-Derived Induced Pluripotent Stem Cells

利用患者来源的诱导多能干细胞预测代谢功能障碍相关脂肪肝疾病风险

Qin, Yuanyuan; Chhetri, Parth; Theusch, Elizabeth; Lim, Grace; Teker, Sheila; Kuang, Yu-Lin; Aziziraftar, Shahrbanoo Keshavarz; Mehraban, Mohammad Hossein; Munoz-Howell, Antonio; Saxena, Varun; Le Guillou, Dounia; Mattis, Aras N; Maher, Jacquelyn J; Medina, Marisa W

Discrepancy in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence in a Large Northern California Cohort

北加州大型队列研究中代谢功能障碍相关脂肪肝疾病患病率的差异

Rodriguez, Luis A; Tucker, Lue-Yen S; Saxena, Varun; Levin, Theodore R

IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis C

IFNL4基因型和其他个人特征可用于预测慢性丙型肝炎患者对为期8周的索非布韦治疗的疗效。

O'Brien, Thomas R; Witt, David J; Saxena, Varun; Morrissey, Kerry Grace; Chen, Sabrina; Baker, Francine S; Prokunina-Olsson, Ludmila; Pfeiffer, Ruth M; Lai, Jennifer B

Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease

代谢功能障碍相关脂肪肝疾病中的肝细胞癌

Rodriguez, Luis A; Schmittdiel, Julie A; Liu, Liyan; Macdonald, Brock A; Balasubramanian, Sreepriya; Chai, Krisna P; Seo, Suk I; Mukhtar, Nizar; Levin, Theodore R; Saxena, Varun

Survival Outcomes Among Patients With Hepatocellular Carcinoma in a Large Integrated US Health System

美国大型综合医疗系统中肝细胞癌患者的生存结果

Yilma, Mignote; Houhong Xu, Richie; Saxena, Varun; Muzzin, Monica; Tucker, Lue-Yen; Lee, Jeffrey; Mehta, Neil; Mukhtar, Nizar

Aged AG129 mice support the generation of highly virulent novel mouse-adapted DENV (1-4) viruses exhibiting neuropathogenesis and high lethality

老年 AG129 小鼠支持产生具有神经致病性和高致死率的新型小鼠适应性 DENV (1-4) 病毒

Gazala Siddqui, Preeti Vishwakarma, Shikha Saxena, Varun Kumar, Sneh Bajpai, Amit Kumar, Satish Kumar, Ritika Khatri, Jaskaran Kaur, Sankar Bhattacharya, Shubbir Ahmed, Gulam Hussain Syed, Yashwant Kumar, Sweety Samal

Primary Care Utilization, Preventative Screening, and Control of Metabolic Syndrome in Metabolic Dysfunction-Associated Steatohepatitis Liver Transplant Recipients

代谢功能障碍相关脂肪性肝炎肝移植受者初级保健利用、预防性筛查和代谢综合征控制

Flynn, Sarah J; Saxena, Varun; Brandman, Danielle

Comparing the Risk of Poor Outcomes Among Hepatitis C-Infected, Cured, and Never-Infected Controls

比较丙型肝炎感染者、治愈者和从未感染者对照组的不良结局风险

Saxena, Varun; Wu, Weilu; Balasubramanian, Sreepriya; Mukhtar, Nizar; Seo, Suk I; Ready, Joanna B; MacDonald, Brock A; Schmittdiel, Julie A